RYR2 and heart disorder: The altered phosphorylation status of RyR2 and changes in the activity of associated kinases and phosphatases have long been implicated in aberrant Ca2+ cycling, and this has been well documented in many animal models of cardiac disease, as well as in humans [29,30].